Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity Roots Analysis has announced the addition of “Cell Therapy Manufacturing market (3rd Edition), 2019 – 2030” report to its […]
Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market Read More »